Dave Moenning
Dave Moenning (RSS)
Proprietor of StateoftheMarkets.com

David Moenning is the President and Chief Investment Strategist for Heritage Capital Management, a Chicago based SEC Registered Investment Advisory firm which he founded in 1989.

Read complete bio
Recent Articles

Bull’s Eye Report: Amgen (AMGN)

May. 24, 2013, 11:51 am EDT – If you're late to the biotech trade, AMGN still offers a great trading opportunity in the short-term. More 

Bull’s Eye Report: Brown-Forman Corp. (BF.B)

May. 23, 2013, 11:40 am EDT – This liquor manufacturer and distributor is a top buy today at current levels, and would be even more attractive if it bounces off its 50-day MA. More 

Bull’s Eye Report: j2 Global (JCOM)

May. 22, 2013, 1:18 pm EDT – This cloud computing stock has positive technicals and is showing a good entry point today. More 

Bull’s Eye Report: Targa Resources Corp. (TRGP)

May. 21, 2013, 2:21 pm EDT – TRGP looks to be exiting its consolidation phase to the upside, so now would be a good time to pick it up. More 

Bull’s Eye Report: Fidelity National Financial (FNF)

May. 20, 2013, 1:32 pm EDT – If sector rotation into financials is the next big move, then FNF could be a great pick for more than just the short term gain back to $27. More 

Bull’s Eye Report:Isis Pharmaceuticals (ISIS)

May. 17, 2013, 12:32 pm EDT – Biotechs are blowing up -- and ISIS Pharmaceuticals (ISIS) is showing an attractive buy right now with potential 12% upside. More 

Bull’s Eye Report: AMERCO (UHAL)

May. 16, 2013, 11:43 am EDT – AMERCO (UHAL), which you might know better as the company behind U-Haul moving trucks, has the technicals to support a buy at current levels for a run back up to March's highs. More 

Bull’s Eye Report: Kinder Morgan Management (KMR)

May. 15, 2013, 12:04 pm EDT – Oil stock Kinder Morgan Management (KMR) is showing several technical signs of a runup to this April's highs. More 

Bull’s Eye Report: Alere (ALR)

May. 14, 2013, 12:16 pm EDT – Healthcare supply companies like Alere (ALR) have flown under the radar...much to the benefit of those smart enough to own them. Today is presenting a good entry opportunity. More 

Bull’s Eye Report: Acorda Therapeutics (ACOR)

May. 13, 2013, 11:44 am EDT – Though lackluster earnings are usually a reason NOT to buy a stock, ACOR gracefully bottomed and based above the 50-day moving average last week and looks to be turning around. More